Mauro David J's Form 4 filing
Prelude Therapeutics Inc (PRLD) · filed Aug 9, 2021
- Accession no.
- 0001209191-21-050404
- Filed
- Aug 9, 2021
- Trade date
- Aug 5, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $466.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mauro David JCIK 0001621172 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2021 | Common Stock | MOption exerciseAcquired | +15,000 | $1.89 | +$28,350 | 15,000 | Direct | |
| Aug 5, 2021 | Common Stock | SSaleDisposed | −6,116 | $29.93 | −$183,051.88 | 8,884 | Direct | |
| Aug 5, 2021 | Common Stock | SSaleDisposed | −2,063 | $31.03 | −$64,014.89 | 6,821 | Direct | |
| Aug 5, 2021 | Common Stock | SSaleDisposed | −6,721 | $32.15 | −$216,080.15 | 100 | Direct | |
| Aug 5, 2021 | Common Stock | SSaleDisposed | −100 | $32.63 | −$3,263 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2021 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 167,610 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.